Skip to main content
BTC / USDT107,400+2.19%ETH / USDT3,840+2.13%SOL / USDT182.40−1.99%BNB / USDT652.30+0.66%XRP / USDT2.2150+1.61%DOGE / USDT0.3850−1.79%TON / USDT5.240+2.34%AVAX / USDT42.60−2.07%LINK / USDT22.40+2.28%ADA / USDT1.0520−1.68%TRX / USDT0.3300+0.92%DOT / USDT8.420+2.93%BTC / USDT107,400+2.19%ETH / USDT3,840+2.13%SOL / USDT182.40−1.99%BNB / USDT652.30+0.66%XRP / USDT2.2150+1.61%DOGE / USDT0.3850−1.79%TON / USDT5.240+2.34%AVAX / USDT42.60−2.07%LINK / USDT22.40+2.28%ADA / USDT1.0520−1.68%TRX / USDT0.3300+0.92%DOT / USDT8.420+2.93%
Pricing
stocksJul 30, 2026, 10:09 AM

Cigna Beats Q2 Earnings and Revenue Estimates, Lifts Annual Guidance

Cigna reported Q2 2026 adjusted EPS of $7.78 and revenue of $71.56 billion, both above analyst expectations. The company also raised its full-year adjusted EPS outlook to at least $30.45.

CI

Cigna posted second-quarter 2026 results that exceeded Wall Street forecasts. Adjusted earnings per share came in at $7.78, surpassing the consensus estimate of $7.60. Adjusted revenue reached $71.56 billion, ahead of the projected $70.34 billion.

The company's Cigna Healthcare medical care ratio – a key metric for insurers – was 84.5%, in line with the estimated 84.46%. For the full year, management now expects the medical care ratio to range between 83.7% and 84.7%, compared to the estimate of 83.97%.

Looking ahead, Cigna raised its full-year adjusted EPS outlook to at least $30.45, edging above the analyst expectation of $30.41. The improved guidance reflects confidence in the company's performance for the remainder of the fiscal year.

Source: First Squawk